Based on the resounding success of last year’s inaugural 2 day program dedicated to Oligonucleotide CMC & Regulatory Strategies we will once again be adding this content to complement our established Oligonucleotide Discovery and Delivery conference. In addition, we deliver two in-depth symposiums focusing on Rare Disease Drug Development and NEW for 2020: AI in Drug Discovery and Development. Bringing together leading discovery scientists, developers, CMC experts, regulatory specialists and technology providers, OPT Congress provides a unique opportunity to discuss advances in next-generation oligonucleotide therapies throughout the drug development process. Attend in 2020 to optimize your drug design, delivery and performance, accelerate time to market and achieve commercial success.

2020 Programs

MARCH 17-18, 2020

5th Annual Oligonucleotide Discovery and Delivery: Optimizing Design, Delivery and Performance

2nd Annual Oligonucleotide CMC and Regulatory Strategies: Accelerating Product Development and Commercial Success

MARCH 19, 2020

Inaugural Artificial Intelligence for Drug Discovery & Development: Applications From Drug Design to Clinical Trials

3rd Annual Rare Disease Drug Development: New Drug Modalities and Emerging Trends

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag

Oligonucleotide Discovery and Delivery